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Abstract
Pulmonary hypertension (PH) in pregnancy, irrespective of etiology, is associated with significant maternal
morbidity and mortality. This case describes a novel approach to providing anesthesia for a
hemodynamically fragile patient. It demonstrates the careful planning and weighted decision-making that
is required when approaching a parturient with severe pulmonary hypertension. The patient's previous
pulmonary artery catheterization showed right ventricular systolic pressure of 78 mmHg and pulmonary
artery pressure of 78/20 mmHg. The patient presented with worsening dyspnea and a decision was made to
proceed with the termination of pregnancy via dilatation and curettage (D&C). Anesthesia was conducted
with combined intrathecal fentanyl with a paracervical block using lidocaine 2%. The patient had a
complication of post-procedure hemorrhage secondary to uterine atony that required careful monitoring
and judicious use of uterotonic medications. A decision was made to use oxytocin due to its favorable effect
profile compared to other uterotonic medications. We hope this anesthesia technique will aid in the future
management of these challenging cases.
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Introduction
Pulmonary hypertension (PH) can be a primary entity or may result from several underlying systemic
conditions. Pregnancy in patients with PH, irrespective of etiology, is associated with significant maternal
morbidity and mortality ranging from 30% to 50% [1]. Physiological changes associated with pregnancy
include an increase in cardiac output, a decrease in systemic vascular resistance as well a hypercoagulable
state. These changes will lead to worsening pulmonary hypertension and right-sided heart failure as well.
We here describe a parturient with a known history of severe idiopathic pulmonary hypertension who
presented for elective termination of pregnancy through dilation and curettage (D&C). The patient had
worsening dyspnea in this pregnancy and was recently listed for a heart and lung transplant. The patient
underwent successful D&C utilizing only intrathecal fentanyl and a paracervical block with 2% lidocaine.
This method allowed for stringent hemodynamic control while providing sufficient surgical anesthesia.
However, the course was complicated by uterine atony with postpartum hemorrhage which was medically
managed to temporize the situation but required thoughtful and vigilant administration given the
hemodynamic fragility of this patient.

Case Presentation
A 22-year-old female presented for elective termination of pregnancy at 10 weeks gestational age.
The patient's past medical history was significant for primary pulmonary arterial hypertension. She
underwent right heart catheterization four months prior to the presentation which reported a right
ventricular pressure (RVP) of 78/20 mmHg, and pulmonary artery pressure (PAP) of 80/35 mmHg.
Echocardiogram demonstrated a preserved left ventricular ejection fraction (EF) of 65% with evidence of
right ventricular enlargement, tricuspid valve regurgitation and interventricular septum deviated towards
left side. The patient was on three liters per min of home oxygen via nasal cannula as well as endothelin
receptor antagonist (Bosentan), and phosphodiesterase inhibitor (Tadalafil). She was being considered for
eventual heart and lung transplantation.
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The patient reported worsening dyspnea for the past six weeks and symptoms consistent with New York
Heart Association class III. Her oxygen saturation was 92% on three liters per minute of oxygen. The patient
denied fever, cough, sputum production, rigors or shakes. The patient also denied chest pain or palpitations.
Examination showed signs of right-sided heart failure with peripheral edema, congested neck veins and
increased work of breathing. Transthoracic echocardiogram showed features of worsening right-sided heart
functions. Rest of the workup including laboratory studies and electrocardiogram were within normal limits.
A decision was made by her pulmonologist and obstetrician for elective termination of pregnancy.
The patient presented to our facility and was reviewed by senior obstetric and cardiac anesthesiologists.
Considering the patient's significant medical history of pulmonary hypertension, a decision was made to do
a combined spinal anesthesia with intrathecal fentanyl with paracervical block with total of 10 ml of plain
lidocaine 2%. Cardiac anesthesiologist was on standby and ready for transesophageal echocardiogram if any
decompensation or extra monitoring was needed.
Standard American Society of Anesthesia (ASA) monitors were applied including electrocardiogram, blood
pressure, and pulse oximetry. Her ASA physical status was considered to be 4. A peripheral 18-gauge
catheter and a radial arterial line were placed. A spinal anesthetic using 25 micrograms of fentanyl was
instilled at the L3-4 interspace using a 27-gauge pencil-point needle. One mg of midazolam was
administered intravenously (IV) for anxiolysis. A paracervical block was then preformed using 10 ml of 2%
lidocaine as a supplement to spinal fentanyl to address pain from cervical dilation. During the Intraoperative course, her hemodynamics were stable with mean arterial blood pressure above 65 mmHg, and
oxygen saturation above 93%. The patient didn't require any supplemental vasopressors or inotropes. She
didn't feel pain from the D&C.
Following the D&C, the patient had postoperative bleeding from uterine atony. The obstetrician vigorously
massaged the uterus and requested a 10 units bolus of oxytocin followed by an infusion. A calculated
risk/benefit assessment was made, and the authors elected for administering an oxytocin infusion in
escalating dosage as opposed to a bolus method. The patient was stable throughout the 15-minute event
and had an uneventful recovery. Estimated blood loss was less than 500 ml.

Discussion
Physiological changes of pregnancy can lead to high maternal morbidity and mortality in patients with PH
[2,3]. Moreover, most of the drugs used for the optimal treatment of PH are contraindicated in pregnancy
due to teratogenicity which limits the optimization of the patient [4]. The first trimester is widely regarded
as the safest time for therapeutic abortion, as pregnancy-related plasma volume changes are less
pronounced. The physiological parameters to be mindful of when choosing an anesthetic plan involve
optimizing the systemic and right atrial pressures, maintaining a judicious fluid balance, and avoiding
factors that may increase PAP [5-7] (see Table 1).

Factors that increase PVR

Factors that decrease PVR

Low FiO2

High FiO2

High PaCO2

Low PaCO 2

Acidosis

Alkalosis

High airway pressure and PEEP

Spontaneous breathing and low PEEP

Hypothermia

Nitric oxide

Vasopressors

Vasodilator e.g., Nitroglycerine

Epinephrine

Dobutamine, milrinone

TABLE 1: Factors that increase and decrease pulmonary vascular resistance
PVR: Pulmonary vascular resistance, FiO2: Inspired oxygen concentration, PaCO2: Arterial carbon dioxide tension, PEEP: Positive end-expiratory
pressure

During the perioperative period, in addition to standard ASA monitoring, invasive blood pressure
monitoring and the ability for close monitoring of RV function is essential. A pulmonary artery catheter
might be indicated, but there is no consensus regarding its routine use. In anticipation of hemodynamic
compromise, intravenous prostaglandin (PG) along with the vasopressors and inotropic agents should be
readily available [8]. General anesthesia (GA) has many drawbacks in patients with PH as it may be
associated with a decrease in cardiac contractility, an increase in PVR and mean pulmonary arterial pressure
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(mPAP) during laryngoscopy and intubation or positive-pressure ventilation [9]. Consequently, there is a
significantly increased risk of mortality in patients receiving GA as compared to regional anesthesia. Using
large doses of local anesthetic (LA) in a single-shot spinal should be avoided as it may induce extensive
sensory and motor block along with hypotension which may increase the risk of hemodynamic instability
[10]. A titrated epidural anesthetic has traditionally been considered the best approach to regional
anesthesia [11]. A low dose of LA via combined spinal-epidural anesthesia is also an attractive option as it
provides a denser perineal sensory block than epidural anesthesia alone, with minimal risk of hypotension
[11,12]. However, the use of an intrathecal opioid without any LA can provide excellent analgesia and is an
apt technique for short procedures like a D&C. However, the advantage of using an opioid only spinal
technique is that there is minimal concern for major hemodynamic derangement. Another opinion is to
supplement paracervical block with IV short-acting opioids such as fentanyl rather than intrathecal opioids.
However, this can come at the cost of systemic side effects of opioids, for example, respiratory depression.
The literature has demonstrated that a paracervical block (Figure 1) [13] is insufficient as a sole anesthetic
for a D&C [14]. The concern of using an opioid only spinal technique is that the analgesic may also be
insufficient as the sole anesthetic. Given that the complications associated with a paracervical block are rare,
the addition of a paracervical block can be used to supplement the opioid only spinal technique.

FIGURE 1: Paracervical block
Red arrow: Left-sided paracervical block at 4 o'clock position, Blue arrow: Right-sided paracervical block at 8
o'clock position
Source: NYSORA.COM, NYSORA grants the permission to download and use NYSORA’s teaching material [15].

Once uterine atony is diagnosed, uterine massage is initiated. Either during the massage or once the
massage fails to yield the desired results, uterotonic agents should be considered. The first-line drug for
uterine atony is oxytocin. The plasma half-life of oxytocin is one to six minutes, and the clinical response is
within minutes with IV administration. The physician should be aware that oxytocin, especially the IV push,
can cause hypotension via systemic vasodilation and can exacerbate PH by impeding right coronary blood
flow leading to RV failure. Furthermore, the post-abortion uterus in the first and second trimester has fewer
oxytocin receptors which might lead to a therapeutic failure or lower the efficacy of the drug [16]. Other
alternatives to oxytocin that are commonly employed in the general population are ergot alkaloids and
prostaglandins. In a setting of PH, ergot alkaloids are contraindicated in the parturient with primary
pulmonary hypertension and can increase mPAP leading to decompensated RV failure [17] or coronary
vasospasm [18]. Prostaglandins employed as uterotonic agents include carboprost and misoprostol.
Carboprost has a similar pharmacodynamic effect on pulmonary vasculature as ergot alkaloids and is
unsuitable for PH subjects [19]. Misoprostol is reported to have no cardiac effects and can be used as an
alternative or in addition to oxytocin. However, its efficacy as a uterotonic agent is not well documented and
limited to a few cases reports.

Conclusions
Our observations reveal that spinal opioids in conjunction with a paracervical block are an effective and safe
anesthetic approach during elective termination of pregnancy in a parturient with PH. Another alternative
to spinal opioids is to consider titrated doses of IV short-acting opioids such as fentanyl with careful
monitoring of respiratory status and systemic side effects. With patients who have PH, one should always
anticipate adverse hemodynamic instability and have a therapeutic algorithm for potential complications.
Regardless of recent medical advances and despite optimal strategies, the PH parturient may rapidly
decompensate. The use of oxytocin infusion in escalating doses can safely terminate uterine atony during
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early pregnancy without adverse events on patients with PH. A perioperative therapeutic algorithm is vital
for managing complications in patients with PH. A multi-disciplinary approach is indispensable for positive
outcomes in subjects with PH.
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